{
  "id": "enwiki-001360364413",
  "slug": "ipalt",
  "title": "IPALT",
  "qid": "",
  "lead": "iPALT, or ALiPT, also known as N-isopropyl-N-allyltryptamine or by its developmental code name ASR-3003, is a serotonin receptor modulator of the tryptamine family. It is an asymmetrical analogue of diisopropyltryptamine (DiPT) and diallyltryptamine (DALT). The drug is a non-selective serotonin receptor agonist, including of the serotonin 5-HT 1B , 5-HT 2A , 5-HT 2B , and 5-HT 6 receptors, but not of the serotonin 5-HT 1A receptor. It is also a serotonin reuptake inhibitor, but does not inhibit dopamine or norepinephrine reuptake. The drug shows rather low potency for many of these actions, with for example 47-fold lower potency as a serotonin 5-HT 2A receptor agonist than the known psychedelic drug 5-MeO-iPALT (ASR-3001). The chemical synthesis of iPALT has been described. Derivatives of iPALT include 5-MeO-iPALT (ASR-3001), 4-HO-iPALT, and 2-Me-iPALT (ASR-3002). 5-MeO-iPALT is known to be a psychedelic drug in humans and is under development for potential medical use. iPALT was patented by the Alexander Shulgin Research Institute (ASRI) in 2024.",
  "body": "iPALT, or ALiPT, also known as N-isopropyl-N-allyltryptamine or by its developmental code name ASR-3003, is a serotonin receptor modulator of the tryptamine family. It is an asymmetrical analogue of diisopropyltryptamine (DiPT) and diallyltryptamine (DALT). The drug is a non-selective serotonin receptor agonist, including of the serotonin 5-HT 1B , 5-HT 2A , 5-HT 2B , and 5-HT 6 receptors, but not of the serotonin 5-HT 1A receptor. It is also a serotonin reuptake inhibitor, but does not inhibit dopamine or norepinephrine reuptake. The drug shows rather low potency for many of these actions, with for example 47-fold lower potency as a serotonin 5-HT 2A receptor agonist than the known psychedelic drug 5-MeO-iPALT (ASR-3001). The chemical synthesis of iPALT has been described. Derivatives of iPALT include 5-MeO-iPALT (ASR-3001), 4-HO-iPALT, and 2-Me-iPALT (ASR-3002). 5-MeO-iPALT is known to be a psychedelic drug in humans and is under development for potential medical use. iPALT was patented by the Alexander Shulgin Research Institute (ASRI) in 2024.",
  "categories": [
    "106462793",
    "106462794",
    "107077446",
    "108147884",
    "129309052",
    "23603337",
    "26220375",
    "27236659",
    "33905804",
    "37750075",
    "43371250",
    "50769796",
    "54374437",
    "63001193",
    "63007578",
    "65121944",
    "68150358",
    "73750206",
    "90256262",
    "90256265",
    "90318773",
    "90894244"
  ],
  "license": "CC BY-SA 4.0",
  "source_uri": "https://en.wikipedia.org/w/index.php?oldid=1360364413",
  "content_hash": "",
  "created_at": null,
  "updated_at": 1781996823.0,
  "claims": [],
  "contradictions": [],
  "confidence": 0.6,
  "csl": {
    "id": "enwiki-001360364413",
    "type": "webpage",
    "title": "IPALT",
    "author": [
      {
        "family": "Anticloud FZ LLE",
        "literal": "Anticloud FZ LLE"
      }
    ],
    "container-title": "encyclopegia.org",
    "publisher": "Anticloud FZ LLE",
    "publisher-place": "Dubai, United Arab Emirates",
    "URL": "https://encyclopegia.org/a/ipalt",
    "issued": {
      "date-parts": [
        [
          2026,
          11,
          19
        ]
      ]
    },
    "accessed": {
      "date-parts": [
        [
          2026,
          11,
          19
        ]
      ]
    },
    "license": "CC BY-SA 4.0",
    "DOI": "eo1:enwiki-001360364413",
    "isBasedOn": "https://en.wikipedia.org/w/index.php?oldid=1360364413",
    "note": "Immutable snapshot enwiki-001360364413"
  }
}